TG Therapeutics Inc (NASDAQ:TGTX)

14.85
Delayed Data
As of Mar 04
 +0.72 / +5.10%
Today’s Change
4.42
Today|||52-Week Range
18.88
-6.25%
Year-to-Date

Today’s Trading

Previous close14.13
Today’s open14.51
Day’s range14.13 - 15.22
Volume385,467
Average volume (3 months)606,884
Market cap$621.2M
Dividend yield--
Data as of 4:00pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-59.01%
Earnings growth (next 5 years)--
Revenue growth (last year)+699.98%
P/E ratioNM
Price/Sales650.44
Price/Book12.10

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc-0.01-0.06%
AMPHAmphastar Pharmaceut...+0.47+3.35%
FLMLFlamel Technologies ...-0.06-0.38%
VSARVersartis Inc+1.32+6.57%
Data as of 4:00pm ET, 03/04/2015

Financials

Last reporting dateMarch 5, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$152.4K
Annual profit (last year)-$20.5M
Net profit margin-13,438.82%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael S. Weiss
Chief Financial Officer, Treasurer &
Secretary
Sean A. Power
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account